Literature DB >> 2906442

Apomorphine anorexia: the role of dopamine receptors in the ventral forebrain.

A Towell1, P Willner, R Muscat.   

Abstract

The inhibition of feeding following the administration of apomorphine, systemically or directly into the nucleus accumbens/ventral striatum, was studied using a microstructural analysis paradigm. On systemic administration, apomorphine reduced food consumption, eating rate and eating time; the effects were blocked by sulpiride but not by SCH-23390. Two doses of apomorphine were administered centrally. Both doses reduced total food intake and eating rate; only the higher dose also reduced eating time; all of these effects were blocked by sulpiride pretreatment. Only the lower dose reduced locomotor activity and rearing in the open field. The results suggest that apomorphine reduces eating rate by an action on dopamine (DA) axon terminal autoreceptors. We have previously demonstrated that apomorphine reduces eating time by an action on DA cell body autoreceptors. Therefore, the two populations of DA autoreceptors appear to be differentially involved in behaviour.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906442     DOI: 10.1007/BF02431545

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Dopamine autoreceptors in the ventral tegmental area show subsensitivity following withdrawal from chronic antidepressant drug treatment.

Authors:  A Towell; P Willner; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Efferents and afferents of the ventral tegmental-A10 region studied after local injection of [3H]leucine and horseradish peroxidase.

Authors:  H Simon; M Le Moal; A Calas
Journal:  Brain Res       Date:  1979-12-07       Impact factor: 3.252

3.  Apomorphine anorexia: a behavioural and neuropharmacological analysis.

Authors:  P Willner; A Towell; R Muscat
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

4.  Neuroleptic antagonism of the motor inhibitory effects of apomorphine within the nucleus accumbens: drug interaction at presynaptic receptors?

Authors:  B Costall; D H Fortune; S C Hui; R J Naylor
Journal:  Eur J Pharmacol       Date:  1980-05-16       Impact factor: 4.432

5.  Apomorphine anorexia: a further pharmacological characterization.

Authors:  R Muscat; P Willner; A Towell
Journal:  Eur J Pharmacol       Date:  1986-04-09       Impact factor: 4.432

6.  Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity.

Authors:  J M Van Ree; G Wolterink
Journal:  Eur J Pharmacol       Date:  1981-06-10       Impact factor: 4.432

7.  SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.

Authors:  G R Breese; R A Mueller
Journal:  Eur J Pharmacol       Date:  1985-07-11       Impact factor: 4.432

8.  Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate.

Authors:  D L Jones; S L Berg; R L Dorris; R E Dill
Journal:  Pharmacol Biochem Behav       Date:  1981-08       Impact factor: 3.533

9.  Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics.

Authors:  A V Christensen; J Arnt; J Hyttel; J J Larsen; O Svendsen
Journal:  Life Sci       Date:  1984-04-16       Impact factor: 5.037

10.  Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.

Authors:  L Ståhle; U Ungerstedt
Journal:  Pharmacol Biochem Behav       Date:  1986-08       Impact factor: 3.533

View more
  2 in total

1.  Inhibitory neurotransmitter serotonin and excitatory neurotransmitter dopamine both decrease food intake in Chinese perch (Siniperca chuatsi).

Authors:  Yu-Hui He; Ling Li; Xu-Fang Liang; Shan He; Luo Zhao; Yan-Peng Zhang
Journal:  Fish Physiol Biochem       Date:  2017-09-19       Impact factor: 2.794

2.  Feeding induced by cannabinoids is mediated independently of the melanocortin system.

Authors:  Puspha Sinnayah; Erin E Jobst; Joseph A Rathner; Angela D Caldera-Siu; Luciana Tonelli-Lemos; Aaron J Eusterbrock; Pablo J Enriori; Emmanuel N Pothos; Kevin L Grove; Michael A Cowley
Journal:  PLoS One       Date:  2008-05-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.